Therapeutic management of in-stent thrombosis after thoracic endovascular aortic repair for blunt thoracic aortic injury in a coronavirus disease 2019 patient

Karen van Rijn; Abbey Schepers; Rutger W van der Meer; Carla S P van Rijswijk; Jan van Schaik; Joost R van der Vorst

doi:10.1016/j.jvscit.2023.101297

Therapeutic management of in-stent thrombosis after thoracic endovascular aortic repair for blunt thoracic aortic injury in a coronavirus disease 2019 patient

J Vasc Surg Cases Innov Tech. 2023 Aug 15;9(4):101297. doi: 10.1016/j.jvscit.2023.101297. eCollection 2023 Dec.

Authors

Karen van Rijn¹, Abbey Schepers¹, Rutger W van der Meer², Carla S P van Rijswijk², Jan van Schaik¹, Joost R van der Vorst¹

Affiliations

¹ Department of Vascular Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
² Department of Radiology, Leiden University Medical Centre, Leiden, The Netherlands.

Abstract

A 27-year-old man underwent thoracic endovascular aortic repair for blunt thoracic aortic injury. Fourteen months later, he presented with intermittent paraplegia, congestive heart failure, and a decline of kidney function as a result of high-grade aortic stenosis caused by in-stent thrombosis. He had a concurrent infection with coronavirus disease 2019. The patient was successfully treated using axillofemoral bypass, followed by stent relining 2 weeks later. The possible risk factors and the optimal therapeutic approach for in-stent thrombosis remain unknown, because only a limited number of cases describing this rare complication have been reported.

Keywords: In-stent thrombosis; Thoracic endovascular aortic repair.

Publication types

Case Reports